Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsOpinionHow Sun Pharma’s diverse business is helping it overcome US FDA curbs on manufacturing plants

    How Sun Pharma’s diverse business is helping it overcome US FDA curbs on manufacturing plants

    Exports from Halol manufacturing plant continue to be restricted

    R. Sree Ram
    September 11, 2025 / 08:18 IST
    Dilip Shanghvi, Chairman of Sun Pharmaceutical Industries
    • PRO Panorama

      Moneycontrol Pro Panorama | A bag of chips full of air

      Nov 20, 2025 / 03:06 PM IST

      Moneycontrol's Pro Panorama November 20 edition: India's trade ties tilt more to China, position your equity portfolio smartly bef...

      Read Now
    Unlock This Article

    Are you a PRO subscriber? Sign In

    What Do You Get

    • Ad free Experience

      Seamless navigation, faster responses.

    • Expert Perspective

      Explore 230+ exclusive editorials every month

    • +

      Uncover Insights from World-Renowned Experts and Journalists

    • Actionable Insights

      40+ weekly investment ideas + 3 to 4 daily technical calls

    • Virtual Events

      Exclusive Live Webinars for Expert Trading & Investment Strategies!

    • Newsletters

      Stay ahead with daily and weekly insights

    View Offers

    Unlock exclusive discounts